Botulinum toxin A in the treatment of hemiplegic spastic foot drop - Clinical and functional outcomes

Singapore Medical Journal

Volumn 41, Issue 5, 2000, Pages 209-213

  Chua, K S G ^a   Kong, K H ^a   Lui, Y C ^b  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b NONE

Author keywords

Botulinum toxin A; Foot drop; Hemiplegia; Plantar flexors; Spasticity

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOOT DISEASE; GAIT; HEMIPLEGIA; HUMAN; JOINT FUNCTION; MALE; SPASTICITY; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXIN TYPE A; FEMALE; GAIT; GAIT DISORDERS, NEUROLOGIC; HEMIPLEGIA; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; TREATMENT OUTCOME;

EID: 0034077397     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP (eds). Spasticity: Disordered motor control. ST Louis, Mosby-Year Book, 1980.
2. Davidoff RA. Antispasticity drugs: mechanisms of action. Ann Neurol 1985; 17:107-116.
3. Penn RD, Kroin JS. Long term Baclofen infusion for treatment of spasticity. J Neurosurg. 1987: 66: 1981-5.
4. Snow BJ, Tsui JKC, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with Botulinum toxin: a double-blind study. Ann Neurol 1990: 28:512-5.
5. Hesse S, Krajnik J, Luecke D, Jahneke MT, Gregoric M, Mauritz KH. Ankle muscle activity before and after Botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke. 1996; 27:455-60.
6. Pierson SH, Katz DI, Tarsy D. Botulinum toxin A in the treatment of spasticity: functional implications and patient selection. Arch Phys Med Rehabil 1996; 77(7):717-21.
7. Hesse S. Lucke D, Malezic M, Bertelt C, Fredrich H, Gregoric N et al. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994; 57:1321-4.
8. Childers MK, Stacy M, Cooke DL, Stonnington HH. Comparison of two injection techniques using Botulinum toxin in spastic hemiplegia. AM J Phys Med Rehabil. 1996; 75:462-9.
9. Bohannon RW, Smith MB. Inter-rater reliability on a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67:206-7.
10. Delagi EF, Perotto A, Iazetti J, Morrison D. Anatomic guide for the electromyographer Springfield, Illinois: CC Thomas, 1980.
11. Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel Index for stroke rehabilitation. Journal of Clinical Epidemiology. 1989; 42(8):703-9.
12. Fugl-Meyer AR, Jassko L, Leyman I et al. The post-stroke hemilegic patient: a method of evaluation of physical performance. Scand J Rehabil Med. 1975; 7:13-31.
13. Burbaud P, Wiart L, Dubos JL, Gaujard E, et al. A randomised, doubleblind placebo-controlled trial of Botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 1996; 61:265-4.
14. Brin MF, Fahn S, Moskowitz C, et al. Localised injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 1987; 2:237-54.
15. Dengler R, Neyer U, Wohl faith K, Bettig U, Janzik HH. Local botulinum toxin in the trea nient of spastic drop foot. J of Neurology. 1992; 239:375-8.